$ALNY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALNYLAM PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALNYLAM PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Sell | S | 65.00 | 32,750 | 2,128,750 | 10,297 | 43 K to 10.3 K (-76.08 %) |
May 17 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, R&D | Buy | M | 31.39 | 32,750 | 1,028,023 | 43,047 | 10.3 K to 43 K (+318.05 %) |
Feb 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | M | 31.29 | 25,000 | 782,250 | 0 | |
Feb 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 40.16 | 4,829 | 193,933 | 140,795 | 145.6 K to 140.8 K (-3.32 %) |
Feb 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 39.72 | 20,171 | 801,192 | 145,624 | 165.8 K to 145.6 K (-12.17 %) |
Feb 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | M | 31.29 | 25,000 | 782,250 | 165,795 | 140.8 K to 165.8 K (+17.76 %) |
Jan 27 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | M | 31.39 | 15,000 | 470,850 | 0 | |
Jan 27 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 37.95 | 15,000 | 569,250 | 140,795 | 155.8 K to 140.8 K (-9.63 %) |
Jan 27 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | M | 31.39 | 15,000 | 470,850 | 155,795 | 140.8 K to 155.8 K (+10.65 %) |
Jan 20 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | M | 15.91 | 15,000 | 238,650 | 0 | |
Jan 20 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 38.20 | 6,200 | 236,840 | 140,795 | 147 K to 140.8 K (-4.22 %) |
Jan 20 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 37.57 | 8,800 | 330,616 | 146,995 | 155.8 K to 147 K (-5.65 %) |
Jan 20 2017 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | M | 15.91 | 15,000 | 238,650 | 155,795 | 140.8 K to 155.8 K (+10.65 %) |
Jan 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 18.66 | 1,340 | 25,004 | 144,641 | |
Jan 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 18.66 | 1,340 | 25,004 | 149,710 | 148.4 K to 149.7 K (+0.90 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 21.35 | 4,356 | 93,001 | 55,994 | |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 18.66 | 4,019 | 74,995 | 45,981 | |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Option Exercise | M | 16.43 | 1,172 | 19,256 | 38,913 | |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Payment of Exercise | F | 37.44 | 5,000 | 187,200 | 10,297 | 15.3 K to 10.3 K (-32.69 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 21.35 | 4,356 | 93,001 | 15,297 | 10.9 K to 15.3 K (+39.81 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 18.66 | 4,019 | 74,995 | 10,941 | 6.9 K to 10.9 K (+58.06 %) |
Jan 04 2017 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D | Buy | M | 16.43 | 1,172 | 19,256 | 6,922 | 5.8 K to 6.9 K (+20.38 %) |
Jan 03 2017 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 0.00 | 8,502 | 0 | 8,502 | |
Dec 22 2016 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 42.22 | 5,550 | 234,321 | 5,550 | |
Dec 22 2016 | ALNY | ALNYLAM PHARMACEUT ... | Gros David-Alexandre C | SVP, Chief Business ... | Option Exercise | A | 42.22 | 25,000 | 1,055,500 | 25,000 | |
Dec 22 2016 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 42.22 | 25,000 | 1,055,500 | 25,000 | |
Dec 22 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Commerci ... | Option Exercise | A | 42.22 | 25,000 | 1,055,500 | 25,000 | |
Dec 22 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | A | 42.22 | 25,000 | 1,055,500 | 25,000 | |
Dec 22 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 42.22 | 25,000 | 1,055,500 | 25,000 | |
Dec 22 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 42.22 | 25,000 | 1,055,500 | 25,000 | |
Dec 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 22.75 | 30,151 | 685,935 | 0 | |
Dec 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 42.61 | 22,710 | 967,673 | 148,370 | 171.1 K to 148.4 K (-13.27 %) |
Dec 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 22.75 | 30,151 | 685,935 | 171,080 | 140.9 K to 171.1 K (+21.39 %) |
Dec 05 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 22.75 | 55,605 | 1,265,014 | 0 | |
Dec 05 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 44.07 | 500 | 22,036 | 88,584 | 89.1 K to 88.6 K (-0.56 %) |
Dec 05 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 43.28 | 16,976 | 734,747 | 89,084 | 106.1 K to 89.1 K (-16.01 %) |
Dec 05 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 42.61 | 14,349 | 611,345 | 106,060 | 120.4 K to 106.1 K (-11.92 %) |
Dec 05 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 22.75 | 55,605 | 1,265,014 | 120,409 | 64.8 K to 120.4 K (+85.80 %) |
Dec 02 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 22.75 | 29,165 | 663,504 | 0 | |
Dec 02 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 46.14 | 1,500 | 69,208 | 5,750 | 7.3 K to 5.8 K (-20.69 %) |
Dec 02 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 45.55 | 13,297 | 605,662 | 7,250 | 20.5 K to 7.3 K (-64.72 %) |
Dec 02 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Sell | S | 44.34 | 14,368 | 637,127 | 20,547 | 34.9 K to 20.5 K (-41.15 %) |
Dec 02 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 22.75 | 29,165 | 663,504 | 34,915 | 5.8 K to 34.9 K (+507.22 %) |
Oct 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Buy | P | 37.00 | 27,900 | 1,032,328 | 27,900 | 0 to 27.9 K |
Oct 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 18.66 | 4,019 | 74,995 | 145,981 | |
Oct 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 7.10 | 3,521 | 24,999 | 135,915 | |
Oct 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 18.66 | 4,019 | 74,995 | 140,929 | 136.9 K to 140.9 K (+2.94 %) |
Oct 14 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 7.10 | 3,521 | 24,999 | 136,910 | 133.4 K to 136.9 K (+2.64 %) |
Sep 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Option Exercise | A | 77.10 | 125,000 | 9,637,500 | 125,000 | |
Jul 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 22.75 | 15,075 | 342,956 | 30,151 | |
Jul 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 22.75 | 15,076 | 342,979 | 45,226 | |
Jul 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Sell | S | 66.00 | 2,418 | 159,586 | 133,389 | 135.8 K to 133.4 K (-1.78 %) |
Jul 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Sell | S | 65.56 | 12,057 | 790,430 | 135,807 | 147.9 K to 135.8 K (-8.15 %) |
Jul 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Sell | S | 64.29 | 600 | 38,575 | 147,864 | 148.5 K to 147.9 K (-0.40 %) |
Jul 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 22.75 | 15,075 | 342,956 | 148,464 | 133.4 K to 148.5 K (+11.30 %) |
Jul 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Sell | S | 64.56 | 1,505 | 97,159 | 133,389 | 134.9 K to 133.4 K (-1.12 %) |
Jul 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Sell | S | 63.73 | 13,571 | 864,839 | 134,894 | 148.5 K to 134.9 K (-9.14 %) |
Jul 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 22.75 | 15,076 | 342,979 | 148,465 | 133.4 K to 148.5 K (+11.30 %) |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | SCHULMAN AMY W | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
Mar 28 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 9.14 | 8,940 | 81,712 | 89,060 | |
Mar 28 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 7.10 | 7,600 | 53,960 | 92,400 | |
Mar 28 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 7.10 | 7,600 | 53,960 | 64,804 | 57.2 K to 64.8 K (+13.29 %) |
Mar 28 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 9.14 | 8,940 | 81,712 | 57,204 | 48.3 K to 57.2 K (+18.52 %) |
Mar 10 2016 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Buy | P | 58.36 | 2,000 | 116,720 | 4,000 | 2 K to 4 K (+100.00 %) |
Feb 25 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | A | 94.14 | 10,000 | 941,400 | 10,000 | |
Feb 24 2016 | ALNY | ALNYLAM PHARMACEUT ... | Gros David-Alexandre C | SVP, Chief Business ... | Buy | P | 62.75 | 900 | 56,475 | 1,000 | 100 to 1,000 (+900.00 %) |
Feb 24 2016 | ALNY | ALNYLAM PHARMACEUT ... | Gros David-Alexandre C | SVP, Chief Business ... | Buy | P | 62.74 | 100 | 6,274 | 100 | 0 to 100 |
Feb 24 2016 | ALNY | ALNYLAM PHARMACEUT ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.18 | 1,000,000 | 7,180,000 | 4,896,716 | 5.9 M to 4.9 M (-16.96 %) |
Feb 03 2016 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 96.45 | 1,987 | 191,646 | 1,987 | |
Feb 03 2016 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 96.45 | 2,750 | 265,238 | 2,750 | |
Feb 03 2016 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | A | 96.45 | 11,709 | 1,129,333 | 11,709 | |
Feb 03 2016 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | A | 96.45 | 15,875 | 1,531,144 | 15,875 | |
Feb 03 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | A | 96.45 | 25,000 | 2,411,250 | 25,000 | |
Feb 03 2016 | ALNY | ALNYLAM PHARMACEUT ... | Sanofi | 10% Owner | Buy | P | 69.75 | 205,030 | 14,300,843 | 10,256,633 | 10.1 M to 10.3 M (+2.04 %) |
Apr 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 22.75 | 15,075 | 342,956 | 60,302 | |
Apr 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 22.75 | 15,076 | 342,979 | 75,377 | |
Apr 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 68.24 | 2,405 | 164,128 | 133,389 | 135.8 K to 133.4 K (-1.77 %) |
Apr 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 67.38 | 12,670 | 853,645 | 135,794 | 148.5 K to 135.8 K (-8.53 %) |
Apr 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 22.75 | 15,075 | 342,956 | 148,464 | 133.4 K to 148.5 K (+11.30 %) |
Apr 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 68.71 | 300 | 20,612 | 133,389 | 133.7 K to 133.4 K (-0.22 %) |
Apr 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 68.00 | 5,405 | 367,555 | 133,689 | 139.1 K to 133.7 K (-3.89 %) |
Apr 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 67.02 | 9,371 | 628,032 | 139,094 | 148.5 K to 139.1 K (-6.31 %) |
Apr 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 22.75 | 15,076 | 342,979 | 148,465 | 133.4 K to 148.5 K (+11.30 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 22.75 | 15,076 | 342,979 | 90,453 | |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 22.75 | 15,076 | 342,979 | 105,529 | |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 74.61 | 325 | 24,249 | 133,389 | 133.7 K to 133.4 K (-0.24 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 73.77 | 1,865 | 137,577 | 133,714 | 135.6 K to 133.7 K (-1.38 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 72.51 | 400 | 29,005 | 135,579 | 136 K to 135.6 K (-0.29 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 71.79 | 1,136 | 81,548 | 135,979 | 137.1 K to 136 K (-0.83 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 70.43 | 930 | 65,498 | 137,115 | 138 K to 137.1 K (-0.67 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 69.40 | 2,114 | 146,704 | 138,045 | 140.2 K to 138 K (-1.51 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 68.35 | 4,406 | 301,155 | 140,159 | 144.6 K to 140.2 K (-3.05 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 67.39 | 2,700 | 181,961 | 144,565 | 147.3 K to 144.6 K (-1.83 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 66.28 | 1,200 | 79,537 | 147,265 | 148.5 K to 147.3 K (-0.81 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 22.75 | 15,076 | 342,979 | 148,465 | 133.4 K to 148.5 K (+11.30 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 78.04 | 200 | 15,608 | 133,389 | 133.6 K to 133.4 K (-0.15 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 76.95 | 200 | 15,390 | 133,589 | 133.8 K to 133.6 K (-0.15 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 75.97 | 2,245 | 170,550 | 133,789 | 136 K to 133.8 K (-1.65 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 75.01 | 3,400 | 255,050 | 136,034 | 139.4 K to 136 K (-2.44 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 74.14 | 5,112 | 378,993 | 139,434 | 144.5 K to 139.4 K (-3.54 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 73.03 | 1,281 | 93,546 | 144,546 | 145.8 K to 144.5 K (-0.88 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 71.81 | 800 | 57,447 | 145,827 | 146.6 K to 145.8 K (-0.55 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 70.95 | 1,838 | 130,401 | 146,627 | 148.5 K to 146.6 K (-1.24 %) |
Jan 21 2016 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 22.75 | 15,076 | 342,979 | 148,465 | 133.4 K to 148.5 K (+11.30 %) |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 88.95 | 14,000 | 1,245,300 | 14,000 | |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 88.95 | 7,200 | 640,440 | 7,200 | |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUT ... | Gros David-Alexandre C | SVP, Chief Business ... | Option Exercise | A | 88.95 | 15,012 | 1,335,317 | 15,012 | |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | A | 88.95 | 30,000 | 2,668,500 | 30,000 | |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | A | 88.95 | 40,000 | 3,558,000 | 40,000 | |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Gift | G | 0.00 | 2,100 | 0 | 48,264 | 50.4 K to 48.3 K (-4.17 %) |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | A | 88.95 | 65,000 | 5,781,750 | 65,000 | |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Gift | G | 0.00 | 4,000 | 0 | 306,996 | 311 K to 307 K (-1.29 %) |
Dec 22 2015 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 88.95 | 25,000 | 2,223,750 | 25,000 | |
Dec 09 2015 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 97.72 | 10,000 | 977,200 | 10,000 | |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | M | 14.74 | 10,000 | 147,400 | 0 | |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | M | 14.05 | 20,000 | 281,000 | 0 | |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 109.00 | 30,000 | 3,270,000 | 140,795 | 170.8 K to 140.8 K (-17.56 %) |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | M | 14.05 | 20,000 | 281,000 | 170,795 | 150.8 K to 170.8 K (+13.26 %) |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | M | 14.74 | 10,000 | 147,400 | 150,795 | 140.8 K to 150.8 K (+7.10 %) |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 13.12 | 58,689 | 770,000 | 0 | |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 106.60 | 700 | 74,622 | 133,389 | 134.1 K to 133.4 K (-0.52 %) |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 106.02 | 16,984 | 1,800,596 | 134,089 | 151.1 K to 134.1 K (-11.24 %) |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 105.16 | 20,238 | 2,128,192 | 151,073 | 171.3 K to 151.1 K (-11.81 %) |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 104.00 | 10,784 | 1,121,541 | 171,311 | 182.1 K to 171.3 K (-5.92 %) |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 103.15 | 9,983 | 1,029,764 | 182,095 | 192.1 K to 182.1 K (-5.20 %) |
Dec 04 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 13.12 | 58,689 | 770,000 | 192,078 | 133.4 K to 192.1 K (+44.00 %) |
Nov 30 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 22.75 | 835 | 18,996 | 29,165 | |
Nov 30 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Option Exercise | M | 16.43 | 4,915 | 80,753 | 40,085 | |
Nov 30 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 16.43 | 4,915 | 80,753 | 5,750 | 835 to 5.8 K (+588.62 %) |
Nov 30 2015 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, R&D, CMO | Buy | M | 22.75 | 835 | 18,996 | 835 | 0 to 835 |
Nov 20 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 7.10 | 10,564 | 75,004 | 139,436 | |
Nov 20 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 13.12 | 58,690 | 770,013 | 58,689 | |
Nov 20 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 103.97 | 8,070 | 839,023 | 133,389 | 141.5 K to 133.4 K (-5.70 %) |
Nov 20 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 103.13 | 23,483 | 2,421,832 | 141,459 | 164.9 K to 141.5 K (-14.24 %) |
Nov 20 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 102.34 | 27,137 | 2,777,078 | 164,942 | 192.1 K to 164.9 K (-14.13 %) |
Nov 20 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 7.10 | 10,564 | 75,004 | 192,079 | 181.5 K to 192.1 K (+5.82 %) |
Nov 20 2015 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 13.12 | 58,690 | 770,013 | 181,515 | 122.8 K to 181.5 K (+47.78 %) |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 9.30 | 25,000 | 232,500 | 0 | |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 15.82 | 25,000 | 395,500 | 0 | |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 11.33 | 12,500 | 141,625 | 0 | |
Nov 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 11.33 | 12,500 | 141,625 | 12,500 |